ArticleMedicine2020

Efficacy and safety of evocalcet in treatment of secondary hyperparathyroidism in chronic kidney disease on hemodialysis patients: A protocol for a systematic review and meta-analysis.

Jing Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.